Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
About
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
About
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Filter
News
Articles
Podcasts
Infographics
Taking medical education into a new dimension
Learn about how 3D human technology offers pharmaceutical companies a fresh and exciting way to take medical education to new heights.
Read more
How can pharma companies create successful ERGs?
For pharma, building an ERG can be essential for inclusivity. Find out how to create a great one with these top tips.
Kite Pharma’s Christi Shaw on the story behind her drive
Christi Shaw, former CEO, Kite Pharma, shares her thoughts on improving access to cell therapies and her motivations for working in oncology
Pharma in the US
Exploring the current state of the US pharmaceutical market, this article investigates the balance between innovation and access to care in the country.
My journey with diversity, equity and inclusion
Roche’s Davidek Herron offers his thoughts on the state of diversity, equity and inclusion in the pharma industry.
Mapping a path to personalised medicine
Despite continued advances in personalised medicine, there is still more to be done to encourage policy makers and payers to back these life-changing initiatives.
Pharma in the UK
In 2021, the UK was named the sixth biggest pharmaceutical market, but it’s facing challenges to further growth. Read to find out more.
Breaking the bias in healthcare AI
The future is brimming with possibilities for AI in healthcare, but eliminating bias is imperative, so where should pharma start?
Medical affairs, AI and insight generation
AI holds buckets of potential for medical affairs teams, but it must be adopted considerately and correctly to meet their needs.
Loading posts...
« Previous
1
…
3
4
5
6
7
…
29
Next »